For help on how to get the results you want, see our search tips.
1454 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Verkazia (updated)
ciclosporin, Conjunctivitis, Keratitis
Date of authorisation: 06/07/2018,
, 
, Revision: 4, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Truvada (updated)
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 42, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Myfenax (updated)
mycophenolate mofetil, Graft Rejection
Date of authorisation: 21/02/2008,
, Revision: 22, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Juluca (updated)
dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018,
, Revision: 3, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Sandoz (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 20/08/2015,, Revision: 8, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Darzalex (updated)
Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016,, , , Revision: 12, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Temozolomide Teva (updated)
temozolomide, Glioma, Glioblastoma
Date of authorisation: 28/01/2010,, Revision: 19, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Nexium Control (updated)
esomeprazole, Gastroesophageal Reflux
Date of authorisation: 26/08/2013, Revision: 13, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): MicardisPlus (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 19/04/2002, Revision: 29, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Olanzapine Glenmark Europe (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 03/12/2009,, Revision: 13, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trazimera (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018,, 
, Revision: 6, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Halaven (updated)
Eribulin, Breast Neoplasms, Liposarcoma
Date of authorisation: 17/03/2011, Revision: 21, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Targretin (updated)
bexarotene, Lymphoma, T-Cell, Cutaneous
Date of authorisation: 29/03/2001, Revision: 20, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Benlysta (updated)
belimumab, Lupus Erythematosus, Systemic
Date of authorisation: 13/07/2011,, Revision: 21, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trajenta (updated)
linagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 23/08/2011, Revision: 16, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Actelsar HCT (updated)
telmisartan, hydrochlorothiazide,
Date of authorisation: 13/03/2013,, Revision: 10, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Dovato (updated)
dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 01/07/2019, Revision: 3, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Trogarzo (updated)
Ibalizumab, HIV Infections
Date of authorisation: 26/09/2019,, Revision: 2, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Elocta (updated)
efmoroctocog alfa, Hemophilia A
Date of authorisation: 18/11/2015,, Revision: 9, Authorised, Last updated: 08/07/2020
-
List item
Human medicine European public assessment report (EPAR): Arsenic trioxide Accord (updated)
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019,, Revision: 1, Authorised, Last updated: 08/07/2020
-
List item
Human medicine European public assessment report (EPAR): Picato (updated)
Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012,
, , Revision: 9, Withdrawn, Last updated: 08/07/2020
-
List item
Human medicine European public assessment report (EPAR): Dafiro HCT (updated)
Amlodipine besylate, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 19, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Cotellic (updated)
cobimetinib hemifumarate, Melanoma
Date of authorisation: 20/11/2015,, Revision: 8, Authorised, Last updated: 07/07/2020
-
List item
Human medicine European public assessment report (EPAR): Zerbaxa (updated)
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015, Revision: 12, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Exforge HCT (updated)
Amlodipine besylate, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 15/10/2009, Revision: 17, Authorised, Last updated: 07/07/2020